2022. Studying The Impact of Plasminogen Activator Inhibitor -1 and Some Biochemical Parameters In Iraqi Children with Type -1 Diabetes Mellitus. Journal of Pharmaceutical Negative Results. 13, 1 (Jan. 2022), 35–38.